day 1 agenda

Scientific Program
Day-1 (Mar 20, 2024)
Important Note: (Program runs in CET Time Zone) 
   
10:20-10:40 Title: EBV antibody and gastric cancer risk a population based nested case-control study in southern China
Yun Du, Cancer Research Institute of Zhongshan City, China
   
10:40-11:00 Title: Post operative pancreatic fistula rate  following pancreaticojejunostomy with Heidelberg VS Classicial Duct to Mucosa technique a comparative study
Sumanth Subhramaniyam, Dhanalakshmi Srinivasan Institute, India
   
11:00-11:20                      SPEAKER SLOT AVAILABLE
   
11:20-11:40 Title: Alpha enolase (ENO1) and far upstream element binding protein 1 (FUBP1) circulating autoantibodies are negative prognostic factors for pancreatic cancer patient survival
Claudia Curcio, University of Turin, Italy
   
11:40-12:00 Title: Evaluation of Artificial Intelligence Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non Alcoholic Fatty Liver Disease
Pal Novak Kaposi, Semmelweis University, Hungary
   
12:00-12:20 Title: Treatment and prognosis of fibrolamellar hepatocellular carcinoma. A systematic review and meta analysis
Dajana Glavas, University of Padua, Italy
   
12:20-12:40                      SPEAKER SLOT AVAILABLE
   
12:40-13:00 Title: Mysteries of ROS regulation in Helicobacter pylori mediated gastric cancer
Asima Bhattacharyya, National Institute of Science Education and Research, India
   
13:00-13:20 Title:  Gastrointestinal Diseases and Disorders        
Saransh Sharma, Massachusetts Institute of Technology, India
   
13:20-13:40                      SPEAKER SLOT AVAILABLE
   
13:40-14:00 Title: A Case Report on Hematemesis From Gastric Ulcers as an Atypical Presentation of Diffuse Large B Cell Lymphoma
Ayanna Denise Lariosa, San Pedro Hospital, Philippines
   
14:00-14:20                      SPEAKER SLOT AVAILABLE
   
14:20-14:40 Title: Therapeutic Effect of Garlic (Allium sativum) on Mice Model of Early Chronic
Kumari Priyam, All India Institute Of Medical Sciences, India
   
14:40-15:00 Title: The effect of hepatic steatosis on 18F FDG uptake in PET CT examinations of cancer Egyptian patients
Magdy Ali Abdou Gouda, Gulf Medical University, United Arab Emirates
   
15:00-15:20                      SPEAKER SLOT AVAILABLE
   
15:20-15:40 Title: Left side predominant segmental Crohn’s disease of rectosigmoid a diagnostic pitfall leading to treatment failure and ultimately spontaneous colonic perforation a case report and literature review
Mohammad Zulfiqar Ali, Armed Forces Hospitals, Saudi Arabia
   
15:40-16:00 Title: Jejunal Diverticular Stones Presenting as Small Bowel Obstruction a Rare Clinical Entity
Jimmy Mena, Queen Elizabeth Hospital-London, United Kingdom
   
16:00-16:20 Title: Gut microbiome Akkermansia muciniphila coupled with its membrane protein ameliorates intestinal inflammation and promotes epithelial wound healing via mediation of CREBH
Qiaozhu Su, Queen's University Belfast IGFS, United Kingdom
   
16:20-16:40 Title: Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis
Konstantina Alexandropoulos, Icahn School of Medicine at Mount Sinai, United States
   
16:40-17:00                      SPEAKER SLOT AVAILABLE
   
17:00-17:20 Title: Hepatic Bile Formation
Norman B Javitt, NYU Grossman School of Medicine, United States
   
17:20-17:40 Title: Left side predominant segmental Crohn’s disease of rectosigmoid a diagnostic pitfall leading to treatment failure and ultimately spontaneous colonic perforation a case report and literature review
Muhammad Ali Aziz, Armed Forces Hospitals, United States
Note: This is the tentative program only and the program will be updated soon
If any one interested to attend the webinar or to book your speaker slot, please send an email to kelly_michaels@gastroenterology-hepatology.org 

day 2 agenda

Updating Soon...

Download